Bank of New York Mellon’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
Other funds holding IPSC
N
GCP
AC
SIM
QC
Bank of New York Mellon's IPSC Position: Q2 2026 in Review
Bank of New York Mellon increased its Century Therapeutics (IPSC) stake by 2,218% in Q2 2026, buying an estimated $654K and bringing the position to 299,014 shares worth $733K. The position accounts for ﹤0.01% of the portfolio, ranked #3544.
Bank of New York Mellon first reported a position in IPSC in Q3 2021 and has held it in 17 quarters since. 28 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.
- Bank of New York Mellon held 299,014 shares of Century Therapeutics worth $733K as of Q2 2026.
- Bank of New York Mellon bought 286,117 Century Therapeutics shares in Q2 2026, an estimated $654K.
- Century Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3544 holding.
- Bank of New York Mellon first reported a position in Century Therapeutics in Q3 2021 and has held it in 17 quarters since.
- 28 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.